99 related articles for article (PubMed ID: 23889309)
1. Benzo(a)pyrene diolepoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons: association with specific CYP1A1, GSTM1, GSTP1 and EHPX genotypes.
Pastorelli R; Cerri A; Rozio M; Dell'Omo M; Muzi G; Abbritti G; Fanelli R; Airoldi L
Biomarkers; 2001; 6(5):357-74. PubMed ID: 23889309
[TBL] [Abstract][Full Text] [Related]
2. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
3. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
[TBL] [Abstract][Full Text] [Related]
4. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731
[TBL] [Abstract][Full Text] [Related]
5. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
6. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
Pavanello S; Siwinska E; Mielzynska D; Clonfero E
Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
[TBL] [Abstract][Full Text] [Related]
7. Benzo(a)pyrene diolepoxide-haemoglobin and albumin adducts at low levels of benzo(a)pyrene exposure.
Pastorelli R; Guanci M; Cerri A; Minoia C; Carrer P; Negri E; Fanelli R; Airoldi L
Biomarkers; 2000; 5(4):245-51. PubMed ID: 23885977
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
[TBL] [Abstract][Full Text] [Related]
9. BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice.
Liu A; Li X; Zhou L; Yan X; Xia N; Song Z; Cao J; Hao Z; Zhang Z; Liang R; Zhang H
Environ Sci Pollut Res Int; 2023 Oct; 30(48):106549-106561. PubMed ID: 37730975
[TBL] [Abstract][Full Text] [Related]
10. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer].
Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486
[TBL] [Abstract][Full Text] [Related]
11. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
12. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
Tung JN; Wu HH; Chiang CC; Tsai YY; Chou MC; Lee H; Cheng YW
Mol Vis; 2010 Apr; 16():623-9. PubMed ID: 20700368
[TBL] [Abstract][Full Text] [Related]
13. Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers.
Viezzer C; Norppa H; Clonfero E; Gabbani G; Mastrangelo G; Hirvonen A; Celotti L
Mutat Res; 1999 Dec; 431(2):259-69. PubMed ID: 10635992
[TBL] [Abstract][Full Text] [Related]
14. [Biomarkers of gentotoxic risk and metabolic polymorphism].
Pavanello S; Clonfero E
Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
[TBL] [Abstract][Full Text] [Related]
15. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
[TBL] [Abstract][Full Text] [Related]
16. Impact of adduct determination on the assessment of cancer susceptibility.
Bartsch H; Rojas M; Alexandrov K; Risch A
Recent Results Cancer Res; 1998; 154():86-96. PubMed ID: 10026994
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility factors and DNA adducts in peripheral blood mononuclear cells of aluminium smelter workers exposed to polycyclic aromatic hydrocarbons.
Tuominen R; Baranczewski P; Warholm M; Hagmar L; Möller L; Rannug A
Arch Toxicol; 2002 Apr; 76(3):178-86. PubMed ID: 11967624
[TBL] [Abstract][Full Text] [Related]
18. Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH.
Pavanello S; Gabbani G; Mastrangelo G; Brugnone F; Maccacaro G; Clonfero E
Int Arch Occup Environ Health; 1999 Jul; 72(4):238-46. PubMed ID: 10491778
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
[TBL] [Abstract][Full Text] [Related]
20. The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes.
Molina E; Pérez-Morales R; Rubio J; Petrosyan P; Cadena LH; Arlt VM; Phillips DH; Gonsebatt ME
Mutat Res Genet Toxicol Environ Mutagen; 2013 Dec; 758(1-2):62-8. PubMed ID: 24084248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
